10/05/2024  15:56:08 Var. +0.10 Volume Denaro15:57:06 Lettera15:57:11 Capitalizzazione di mercato Dividend Y. Rapporto P/E
50.90EUR +0.20% 64,516
Fatturato: 1.2 mill.
50.85Quantità in denaro: 407 50.95Quantità in lettera: 641 10.51 bill.EUR 2.35% 26.94

Descrizione business

Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange, with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties within the urogenital therapeutic area and of treatments for rare diseases.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Robert Koremans
Consiglio di amministrazione
Andrea Recordati, Giampiero Mazza, Guido Guidi, Joanna Le Couilliard, Michaela Castelli, Piergiorgio Peluso, Cathrin Petty, Giorgio De Palma, Elisa Corghi, Luigi La Corte, Kim Stratton
Consiglio di sorveglianza
Antonio Santi, Andrea Balelli, Ezio Simonelli, Livia Amidani Aliberti, Patrizia Oriundi Paleologo, Emiliano Nitti , Marco Antonio Viganò
 

Dati aziendali

Name: Recordati S.p.A.
Indirizzo: via M. Civitali 1,I-20148 Milano
Telefono: +39-02-48787-1
Fax: +39-02-40073-747
E-mail: -
Internet: www.recordati.com/
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 46.40%
Data dell'IPO: 01/01/1984

Rapporti con gli investitori

Name: Marianne Tatschke
IR telefono: -
IR Fax: +39-02-48787-225
IR e-mail: inver@recordati.it

Company calendar

CW 21 | 20/05/2024 Ex-Dividend
CW 21 | 21/05/2024 Record Date
CW 21 | 22/05/2024 Dividend Payment
CW 31 | 30/07/2024 Interim Report 2nd Quarter/6 Months
CW 45 | 08/11/2024 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

CVC Capital Partners
 
51.80%
Altri
 
48.20%